Primary objective:To examine the effect of stress reduction through heart rate variability (HRV) biofeedback + psycho-education (condition 1) in pregnant women with at least moderate levels of stress, and their partners, as compared to psycho-…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Verhoogd risico op stress en stressgerelateerde klachten
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Numbering corresponds to numbering *Primary Objective*
(a) Perceived stress and anxiety (pregnant women and their partners) assessed
by means of self-report on validated questionnaires; stress physiology of
parameters of the autonomic nervous system (e.g. heart rate, heart rate
variability, pre-ejection period, respiratory sinus arrhythmia, skin
conductance responses) as measured by basal functioning and by responses to a
standardized stress task;
(b) Medical complications during pregnancy; birth outcomes for the mother and
child with regard to: gestational age, birth weight, APGAR scores (1-5
minutes), method of delivery, complications;
(c) Infant behaviour and development: sleep patterns, feeding patterns, crying,
infant temperament, motor and mental development.
Secondary outcome
Numbering corresponds to numbering *Secundary Objectives*
(1) HRV-biofeedback parameters (related to changes in total blood volume).
(2) Usability and validity of the DTI-2.
(3) Diverted attention, using an emotional interference task.
Background summary
There is accumulating evidence that prenatal maternal stress and anxiety may
result in less optimal birth outcomes and has long-lasting adverse consequences
on offspring*s development and behavior. Therefore, reducing maternal stress
and anxiety during pregnancy is of major importance, because it will provide a
fundament for a healthy child development.
A heart rate variability (HRV) biofeedback intervention has been proven to be
effective in reducing stress and to increase adaptation to stressful situations
in several populations, and is expected to be effective in stressed pregnant
women as well. Recent research shows the importance of social support by their
spouse and the major impact of the transition to parenthood for both women and
men in their relationship. Therefore, we ask the spouses to participate in the
intervention study as well.
Although several studies have shown that HRV-biofeedback can serve as a stress
and anxiety reducing intervention, little is known about the mechanisms of this
technique. One hypothesis is that blood volume is related to certain
HRV-biofeedback parameters. In pregnant women, blood volume increases in a
relatively short time, which makes this specific group an ideal population to
study this relationship.
A possible mechanism that may contribute to the reduction of stress and anxiety
via HRV-biofeedback is learning to focus and shift, i.e., regulate, your
attention. To test this hypothesis, an emotional interference task is included
in this study.
Study objective
Primary objective:
To examine the effect of stress reduction through heart rate variability (HRV)
biofeedback + psycho-education (condition 1) in pregnant women with at least
moderate levels of stress, and their partners, as compared to
psycho-educational coaching only (reference condition), on: (a) physiological
and subjective measures of stress, anxiety and well-being for pregnant women
and their partners, (b) birth outcomes for mother and child, and (c) infant
behaviour, development, and well-being (study 1).
Secundary objectives:
(1) To examine the changes in HRV-biofeedback parameters across pregnancy (due
to changes in total blood volume)(study 2).
(2) To test and validate a device for ambulatory monitoring of stress
physiology against the well-validated and commonly used VU-AMS research device
(study 1).
(3) To test the effects of HRV-biofeedback on diverted attention (study 2).
Study design
This study consists of two randomized controlled trails.
Study 1:
Pregnant women, together with their partners or a significant other, are
randomized to either (1) HRV-biofeedback + psycho-educational training or (2)
psycho-education training only (reference condition). Our study further
includes repeated measures of determinants and outcomes during pregnancy and
the first year of life of the infant. In short, repeated measures of outcomes
during pregnancy (stress indices, medical complications, sleep quality; T1 and
T2), at birth (T3: gestational age, birth weight, delivery and birth
complications) and the first year of life at 1 (T4; parental adaptation and
stress indices), 6 & 12 months (T5 & T6: infant behaviour, development,
emotional well-being; parental adaptation and family functioning) will be
conducted. Participation in the study will, therefore, take about 1.5 years.
Study 2:
Pregnant and non-pregnant women are randomized to either a
Biofeedback-immediate group, or a Biofeedback-waitlist group (reference
condition), resulting in four groups: (1) Biofeedback-immediate, pregnant; (2)
Biofeedback-immediate, non-pregnant; (3) Biofeedback-waitlist, pregnant; and
(4) Biofeedback-waitlist, non-pregnant. The study further includes repeated
measures of stress indices, sleep quality and attention. In the
Biofeedback-immediate condition these measurements take place before and after
the training, and six weeks later (follow-up). In the Biofeedback-waitlist
condition, the first two measurements take place before the training, with a
six week period in between, and the third measurement takes place after the
training.
Intervention
Study 1:
Two intervention conditions are part of the study: (1) HRV-biofeedback +
psycho-education, and (2) psycho-education (reference condition). Each
condition will consist of 9 weekly group sessions + 1 reunion session after
birth of 2-2.5 hours, starting in mid-pregnancy. Groups consist of 6 pregnant
women and their partners, led by a well-educated midwife-trainer. Both
conditions will require daily homework practices (max. 40 min.) for
participants.
Study 2:
The heart rate variability biofeedback intervention consists of 5 weekly group
sessions of 60-90 minutes, with daily home practices (40 minutes). Groups
consist of 6 participants.
Study burden and risks
Study 1:
There are no risks anticipated for women, partners, and their (unborn) child
with the study. Burden for the pregnant women and their partners consists of
participating in the intervention, filling out questionnaires, and
physiological measurements. Burden for the child consists of mental and
physical development measurements.
During the intervention, the pregnant women and their partners are asked to
come to our research facility in Amsterdam for nine weekly group sessions of
2-2.5 hours each, with max. 40 min/day of home practice and diary reports
during these weeks.
Both the pregnant women and their partners are asked to fill out questionnaires
twice during pregnancy (approx. 60 minutes per set of questionnaires) and three
times during the first year following birth (approx. 30-40 minutes per set of
questionnaires). Questionnaires can be filled out at home.
For the physiological measurements during pregnancy, the pregnant women and
their partners are asked to visit our research facility in Amsterdam twice. It
will take about 60-90 minutes to complete these measurements.
The child born from this pregnancy is tested two times on mental and physical
development during the first year (at 6 months and 1 year; 45-60 minutes for
each measurement). For these measurements, at least one of the parents is asked
to visit our research facility in Amsterdam with the child.
Study 2:
There are no risks anticipated for the participants. Burden for the
participants consists of participating in the intervention, filling out
questionnaires, and physiological measurements.
During the intervention, participants are asked to come to our research
facility in Amsterdam for five weekly group sessions of 60-90 minutes each,
with 30-40 min/day of home practice and diary reports during these weeks.
Participants will be asked to fill out questionnaires three times (approx.
25-40 minutes for each set of questionnaires). This can be done at home. For
the measurements of the HRV parameters, the participants are asked to visit our
research facility in Amsterdam. It will take about 30-40 minutes to complete
these measurements. Furthermore, an emotional interference tasks is applied
three times, when participants are at our research facility. In this task,
participants are presented with pictures from the widely used International
Affective Picture System (IAPS), and some of the pictures contain an image that
can be experienced as unpleasant (e.g., accidents). This task will take about
15 minutes to complete.
Van der Boechorststraat 1
Amsterdam 1081BT
NL
Van der Boechorststraat 1
Amsterdam 1081BT
NL
Listed location countries
Age
Inclusion criteria
Study 1:
In order to be eligible to participate in this study, a subject must meet all of the following criteria: The pregnant women should be >18 years of age, and <22 weeks pregnant. They should have at least moderate levels of prenatal stress, determined by a score of 22 or higher on the PSS, or a score of 21 or higher on the PRAQ-R.;Study 2:
In order to be eligible to participate in this study, a subject must meet all of the following criteria: For pregnant women see *Study 1* above. The non-pregnant women need to have comparable ages, relevant for matching purposes, and should have at least moderate levels of stress, determined by a score of 22 or higher on the PSS.
Exclusion criteria
Study 1
A potential subject (pregnant woman) who meets any of the following criteria will be excluded from participation in this study: (1) chronic medical conditions such as Diabetes, (2) use of medication which is known to affect cardiovascular stress reactivity measures (e.g., * blockers), (3) substance abuse, (4) insufficient command of the Dutch language required to fill out questionnaires, (5) a score of 16 or higher on the depression scale of the HADS (cut-off score for severe depression), and (6) presence of a history of other severe mental disorders, such as Bipolar disorder or Schizophrenia.;If the partner of the pregnant woman meets any of the following criteria, the couple will be excluded from participation in this study: (1) presence of a history of other severe mental disorders, such as Bipolar disorder or Schizophrenia, (2) substance abuse, (3) insufficient command of the Dutch language required to fill out questionnaires.;Study 2
See exclusion criteria women of study 1.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL46065.029.13 |